Antiphospholipid antibody testing: Which are most useful for diagnosis?

被引:8
作者
Bertolaccini, Maria Laura [1 ]
Hughes, Graham R. V. [1 ]
机构
[1] Kings Coll London, Lupus Res Unit, Rayne Inst,Sch Med, Guys Kings & St Thomas Hosp,St Thomas Hosp, London, England
关键词
D O I
10.1016/j.rdc.2006.05.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The antiphospholipid syndrome (APS) is a systemic autoimmune disease clinically characterized by recurrent arterial or venous thrombosis or pregnancy complications including recurrent early miscarriages or fetal losses. The presence of antiphospholipid antibodies (aPL) is mandatory to make the laboratory diagnosis of APS. In clinical practice, the "gold standard" tests are those that detect anticardiolipin antibodies (aCL) by ELISA or the lupus anticoagulant (LA) by coagulation tests. Although other specificities for aPL have been described, their clinical utility has still to be established.
引用
收藏
页码:455 / +
页数:10
相关论文
共 72 条
[21]   Anti-β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome [J].
Galli, M ;
Luciani, D ;
Bertolini, G ;
Barbui, T .
BLOOD, 2003, 102 (08) :2717-2723
[22]   EFFECT OF ANTIPHOSPHOLIPID ANTIBODIES ON PROCOAGULANT ACTIVITY OF ACTIVATED PLATELETS AND PLATELET-DERIVED MICROVESICLES [J].
GALLI, M ;
BEVERS, EM ;
COMFURIUS, P ;
BARBUI, T ;
ZWAAL, RFA .
BRITISH JOURNAL OF HAEMATOLOGY, 1993, 83 (03) :466-472
[23]   Back to the future: from knowledge management to the management of information and data [J].
Robert D. Galliers ;
Sue Newell .
Information Systems and e-Business Management, 2003, 1 (1) :5-13
[24]  
Galvez J, 1997, MED CLIN-BARCELONA, V108, P396
[25]   The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant [J].
Gardiner, C ;
Mackie, IJ ;
Malia, RG ;
Jones, DW ;
Winter, M ;
Leeming, D ;
Taberner, DA ;
Machin, SJ ;
Greaves, M .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (04) :1230-1235
[26]   ANTICARDIOLIPIN ANTIBODIES AND THE RISK FOR ISCHEMIC STROKE AND VENOUS THROMBOSIS [J].
GINSBURG, KS ;
LIANG, MH ;
NEWCOMER, L ;
GOLDHABER, SZ ;
SCHUR, PH ;
HENNEKENS, CH ;
STAMPFER, MJ .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (12) :997-1002
[27]   Guidelines on the investigation and management of the antiphospholipid syndrome [J].
Greaves, M ;
Cohen, H ;
Machin, SJ ;
Mackie, I .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (04) :704-715
[28]   Revisiting the anticardiolipin test and its standardization [J].
Harris, EN ;
Pierangeli, SS .
LUPUS, 2002, 11 (05) :269-275
[29]   USE OF AN ENZYME-LINKED IMMUNOSORBENT-ASSAY AND OF INHIBITION STUDIES TO DISTINGUISH BETWEEN ANTIBODIES TO CARDIOLIPIN FROM PATIENTS WITH SYPHILIS OR AUTOIMMUNE DISORDERS [J].
HARRIS, EN ;
GHARAVI, AE ;
WASLEY, GD ;
HUGHES, GRV .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (01) :23-31
[30]  
HARRIS EN, 1983, LANCET, V2, P1211